Skip to main content

Table 3 Subgroup analyses of the incidence rate of treatment failure within 90 days, in the intention-to-treat population

From: Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial

  1. low CRP: ≤50 mg/L; high CRP: > 50 mg/L
  2. Abbreviations: CRP C-reactive protein, GOLD Global initiative for chronic Obstructive Lung Disease, guideline 2017, ICS Inhaled corticosteroid